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ABSTRACT: Neutrophil [polymorphonuclear leukocyte (PMN)] transepithelial migration (TEM) is a hallmark of in-
flammatory mucosal disorders. PMN TEM is associated with epithelial injury; however, mechanisms involved in this
process are not well defined. The current work describes a new mechanism whereby deposition of PMNmembrane-
derived microparticles (PMN-MPs) onto intestinal epithelial cells (IECs) during TEM leads to loss of epithelial
cadherins, thus promoting epithelial injury and increased PMN recruitment. PMN-MPs secreted by activated PMNs
during TEMdisplayed a high level of enzymatically active matrix metalloproteinase 9 (MMP-9), andwere capable of
mediating potent effects on IEC integrity. Isolated PMN-MPs efficiently bound to IEC monolayers and induced
cleavage of desmoglein-2 (DSG-2) but not E-cadherin, leading to disruption of IEC intercellular adhesions. Further-
more, PMN-MP binding to intestinal epithelium in vitro in transwell assays and in vivo in ligated intestinal loop
preparations facilitated increases in PMN TEM. These effects were MMP-9 dependent and were reversed in the
presence of specific pharmacological inhibitors. Finally, we demonstrated that IEC Dsg-2 serves as a barrier for
migrating PMNs, and its removal by PMN-MP-associatedMMP-9 facilitates PMN trafficking across epithelial layers.
Our findings thus implicate PMN-MPs in PMN-mediated inflammation and epithelial damage, as observed in in-
flammatorydisorders ofmucosal surfaces.—Butin-Israeli,V.,Houser,M.C., Feng,M.,Thorp, E.B.,Nusrat,A., Parkos,
C.A,Sumagin,R.Depositionofmicroparticlesbyneutrophils onto inflamedepithelium: anewmechanism todisrupt
epithelial intercellular adhesions andpromote transepithelialmigration. FASEB J. 30, 4007–4020 (2016).www.fasebj.org
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Epithelial cells lining the intestinal lumen form a selective
barrier between the luminal contents and the surrounding
tissue. Intestinal epithelial cells (IECs) are held together as
continuous polarized sheets by junctional complexes
composed of desmosomes and adherens and tight junc-
tions. In addition to mediating cellular adhesion and
providing structural support for epithelialmonolayers (1),
junctional adhesion molecules mediate critical signaling
events which maintain epithelial polarity and cell shape
(2), and regulate barrier function, cell motility (3–5), pro-
liferation, and differentiation (6, 7). Constituents of the
epithelial junctions also play key roles in the regulation of
neutrophil [polymorphonuclear leukocyte (PMN)] trans-
epithelial migration (TEM) (8), which is a hallmark of in-
flammatory mucosal disorders.
PMNs navigating between adjacent epithelial cells en-
counter a variety of lateral membrane adhesion receptors
forming the epithelial junctional complexes. Although
some of these receptors can help facilitate PMN TEM, in-
cluding interactions of signal regulatory protein-a and
CD47 (9), othersmay serve as a barrier formigrating PMNs
and are removed from the lateral epithelial surface during
TEM. These inlude E-cadherin, a key component of the
adherens junctions, and occludin, a component of the tight
junctions (10). Desmosomal cadherins are another example
of barrier-forming proteins that may be an obstacle for
PMNs migrating along the basolateral IEC membrane.
Several desmosomal cadherins have been identified in
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human epithelium, with desmoglein-2 (DSG-2) being the
most abundantlyexpressed in the intestinal epithelium(11).
Dsg-2 interacts in transwith itself orwith desmocollin-2
(Dsc-2) to form transmembrane protein complexes (12). It
is linked to the actin cytoskeleton through interactions
with adapter proteins, including plakin, plakoglobin, and
plakophilin (11). Dsg-2 is a key adhesive component, pro-
viding structural support for epithelial monolayers by
mediating cell-to-cell adhesions.However, recent evidence
suggests that Dsg-2 expression affects the expression and
localization of other junctional proteins, thus contributing
to the regulation of epithelial barrier function, cell pro-
liferation,motility, and apoptosis (13).As such, loss ofDsg-
2 results indecreased expressionofDsc-2 (14),mislocalized
expression of junctional proteins zonula occludens (ZO)-1
and coxsackie and adenovirus receptor, resulting in de-
creased IEC proliferation (15) and impaired barrier (16).
Disruption of mucosal barrier function and epithelial
injury are common pathologic features of inflammatory
diseases of the gastrointestinal tract. For example, in-
flammatory bowel diseases encompassing ulcerative co-
litis and Crohn’s disease feature barrier dysfunction and
epithelial injury caused by PMN-mediated inflammation
(17). Symptoms and severity of inflammation correlate
with PMN accumulation in epithelial crypts (18, 19) and
decreased expression of key junctional adhesion mole-
cules E-cadherin, ZO-1, andDsg-2 (20). Thesedata suggest
that PMNsmigrating across IECs cause tissue damage by
altering the expression and localization of junctional ad-
hesionmolecules. Indeed,PMN-elastase,which is secreted
by activatedPMNsduringTEM, has been shown to cleave
E-cadherin and alter IEC polarity (21). Similarly, PMNs
secrete metalloproteinases (MMPs), which are known for
theability tomodify extracellular, soluble, andmembrane-
bound proteins (22). In particular, activated PMNs secrete
an abundance of MMP-9 (23, 24), which has been recently
shown to cleaveDsg-2, depleting it from cellular junctions
(25). Activated PMNs also secrete membrane-derived
microparticles (MPs) (26), which are defined as small ex-
tracellular vesicles ranging from 0.2 to 1.0 mm in diameter
and which contain functional proteins and antigens that
are transported across tissues (26). Microparticles have
recently come into focus as novel modulators of tissue
homeostasis, immunity, and inflammation (27, 28). Pro-
teomic analysis of MPs derived from activated human
PMNs has suggested association of MMP-9 with PMN-
derived MPs (PMN-MPs) (26).
In the current work we present evidence of enzy-
matically active MMP-9 that is observed to associate
with PMN-MPs. PMN-MPs efficiently bound the epi-
thelial membrane to induce MMP-9-dependent cleav-
age of Dsg-2. Depletion of Dsg-2 from IEC junctions led
to decreased intercellular adhesion, destabilization of
IEC monolayers, and enhanced PMN TEM. Given the
observation that en masse infiltration of mucosal tissues
by PMNs is a common feature of pathologic inflam-
mation, accumulation of PMN-MPs containing enzy-
matically active proteases in the inflamed regionsmay
have significant effects on tissue function and con-




C57BL6Jmice (The Jackson Laboratories, BarHarbor,ME,USA),
ages 12–16 wk, were maintained under specific pathogen-free
conditions at Northwestern University–Feinberg School of
Medicine animal facilities. All experimental protocols were ap-
proved by the Institutional Animal Care and Use Committee.
Cells
Human T84 IECs were grown in DMEM-F12 50:50 (Sigma-
Aldrich, St. Louis,MO,USA)with supplements (29). PMNswere
isolated from human blood obtained from healthy volunteers by
density gradient centrifugation (29, 30) andhandled according to
protocols for the protection of human subjects, as approved by
the Northwestern University Institutional Review Board.
Antibodies and reagents
Monoclonal anti-human Dsg-2 (AH12.2) was from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); rabbit polyclonal Dsg-2
(EPR6768) andMMP-9 (EP1254) from Abcam (Cambridge, MA,
USA); and cell mask orange membrane stain from Molecular
Probes (Eugene, OR, USA). Anti-CD11b/CD18 mAb (CBRM1/
29) was purified in-house (31), Isotype control IgG1 and anti-
Ly6G Abs were from BD Biosciences (San Jose, CA, USA), and
HRP-conjugated anti-mouse and anti-rabbit IgGs were from
Jackson ImmunoResearch (West Grove, PA, USA). MMP-9 in-
hibitor II, pan-MMPinhibitor (GM6001),MMP-2 inhibitor IVwere
from EMDMillipore (Billerica, MA, USA). ABTS (2,2’-azinobis-
3-ethylbenzothiazoline-6-sulfonic acid), HBSS with Ca2+ and
Mg2+ (HBSS+) andHBSSwithoutCa2+ andMg2+ (HBSS2),DMEM
including media supplements, Dispase II, chemotactic peptide
formyl-methionyl-leucyl phenylalanine (fMLF), and human
TNF-a were from Sigma-Aldrich. Murine TNF-a was from
PeproTech (Rocky Hill, NJ, USA).
Generation of PMN-MPs
Human PMN-MPs were prepared from the supernatants of
fMLF-stimulated PMNs. Freshly isolated PMNs (2 3 107 cells)
were stimulated with fMLF (1 mM in 200 ml HBSS+, 20 min at
37°C). After stimulation, the supernatants were cleared of cells
and cellular debris by 2-stage centrifugation (400 g followed by
3000 g spins, 10min) and then subjected to ultracentrifugation at
100,000 g. Pelleted MPs were washed and prepared for Western
blot analysis, flow cytometry, or functional assays. For all func-
tional assays, MPs derived from 2 3 106 PMNs were used. For
preparation of murine PMN-MPs, PMNs were isolated from
bonemarrowandenriched to;85–90%purityusingHistopaque
gradients (1077 and 1119; Sigma-Aldrich) as previously de-
scribed (32). Murine PMNs (2 3 107 cells) were then stimulated
with fMLF (5mMin 200ml HBSS+, 20min at 37°C) andMPswere
prepared by using centrifugation methods as described above.
Enzymatic activity of MMP-9 expressed on MPs derived from
both human and mouse PMNs was assessed with a Novex Zy-
mogram gel kit (Thermo Fisher Scientific, Waltham, MA, USA)
according to the manufacturer’s instructions.
PMN migration assays
In vitro, PMN migration (1 3 106 cell/well in HBSS+, 1 h, 37°C)
across epithelial monolayers in the physiologically relevant,
basolateral-to-apical direction was induced with fMLF gradient
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(100 nM) added to low-adhesion plates (33) and quantified by
assaying for thePMNmyeloperoxidase (29). PostmigrationPMNs
(after 3 h migration) were collected and immediately used in ex-
periments. In vivo, animals were anesthetized by intramuscular
injection of ketamine and xylazine mixture at doses of 100 and
5 mg/kg, respectively. A midline abdominal incision was made,
and a 4-cm loop of small intestine was exteriorized and clipped at
the proximal and distal ends. The loops were injected with MPs
(prepared from53 106 bonemarrow–derived PMNs), alone or in
combination with LPS (100 mg/ml in 200 ml sterile HBSS+) and
were reinserted into the peritoneal cavity for 3 h incubation. After
incubation, intestinal loops were isolated and lavaged twice
with 200ml HBSS+. The number of Ly6G+/CD11b+ PMNs in the
lavaged fluid (PMNs that migrated into the intestinal lumen) was
quantifiedwith flowcytometry.When indicated,pharmacological
inhibitorswere introduced to intestinal loops in combinationwith
the MP treatment. At the end of all experimental procedures, the
animals were euthanized via rapid cervical dislocation.
Western blot analysis
IEC monolayers after PMN TEM were lysed in 1% SDS buffer
(with 100mMTris, pH 7.4) containing protease and phosphatase
inhibitors (Sigma-Aldrich) boiled and cleared by centrifugation.
Equal amounts of protein (determined with a bicinchoninic acid
protein assay) or human and mouse MPs (derived from 2 3 106
PMNs, unless otherwise specified)were separated by SDS-PAGE
and transferredontonitrocellulosemembranes.Membraneswere
blocked (5% nonfat milk in 0.05% Tween-20 Tris-buffered saline)
and incubated with appropriate primary antibodies overnight at
4°C, followed by secondary HRP-conjugated antibodies. For
protein analysis in cell supernatants, equal protein loading was
confirmedbyusingPonceaustaining. Silencingexperimentswere
performed on subconfluent monolayers (50–70%) grown on
permeable supports. Small interferingRNA (siRNA) sequences
targeting MMP-9, E-cadherin, and the negative control siRNA
were purchased from Santa Cruz Biotechnology. siRNA se-
quence targeting Dsg-2 was purchased from GE Dharmacon
(Lafayette, CO, USA). siRNAs were delivered twice every 12 h
in Lipofectamine 3000 at the following concentrations: MMP9
(100 nM), E-cadherin (200 nM), and Dsg-2 (200 nM).
Flow cytometry
PMNs, before or after TEM,were collected andprepared for flow
cytometry (33). Total expression of MMP-9 and CD11b was ex-
amined after fixation and permeabilization with the Cytofix/
Cytoperm kit (BD Biosciences) according to the manufacturer’s
instructions. Surface protein expression on human and mouse
MPs was determined by incubating MPs with fluorescently
conjugated antibodies or relevant isotype controls for 40 min on
ice. All cell samples were analyzed by FACS Calibur (BD Bio-
sciences) and FlowJo software (Tree Star, Ashland, OR, USA).
Immunofluorescence labeling
IEC monolayers grown on permeable supports before and after
PMN TEM or cryosections (7-mmwidth) of mouse tissue frozen
in optimum cutting temperature (OCT) compound (Sakura
Finetek,Torrance,CA,USA)wereethanol fixed, blockedwith5%
bovine serum albumin in PBS, and incubated with the relevant
primary antibody (10 mg/ml, overnight at 4°C), either directly
conjugated or followed by an appropriate fluorescently labeled
secondary antibody (1 h at room temperature). All images
were captured with an LSM 510 confocal microscope (Zeiss,
Thornwood, NY, USA) with a plan-Neofluar363 oil objective.
TEM
PMN-MPs were resuspended in PBS and fixed by adding an
equal volumeof 2%paraformaldehyde in0.1Mphosphatebuffer
(pH 7.4), to a final volume of 100 ml. Subsequently, PMN-MPs
were absorbed onto 400-mesh carbon-coated copper grids
(10 min), and imaging was performed with a Tecnai Spirit G2
transmission electron microscope (FEI, Hillsboro, OR, USA).
Mechanical strength (dispase) assay
Confluent IECs in 6-well tissue cultureplateswere serumstarved
for 24 h at 37°C, washed with HBSS+ and treated as indicated.
Both PMNs and PMN-MPs were incubated with IECs for 6 h. In
experiments where pharmacological inhibitors were used, IECs
were pretreated with an appropriate inhibitor (37°C in 2 ml
serum-free medium) for 1 h before initiation of treatment proto-
cols. After treatments, IECs were washed with HBSS+ and in-
cubatedwith 2mlofDispase solution (5mg/ml inHBSS+, 30min
at 37°C). Released monolayers were subjected to mechanical
stress, and fragments were counted with a dissecting scope
(TS100; Nikon, Melville, NY, USA). Data are expressed as the
average number of fragments6 SEM.
Statistics
Statistical significance was assessed by Student’s t test or 1-way
ANOVA with a Newman-Keuls multiple-comparison test, by
using Prism, ver. 4.0 (GraphPad, La Jolla, CA, USA). Statistical
significance was set at P, 0.05.
RESULTS
PMN migration across IEC monolayers results
in cleavage of E-cadherin and Dsg-2
PMNTEMhas been suggested to result in reorganization or
loss of adherens and tight junctional complexes, including
E-cadherin (20, 34). However, it is still unclear whether ex-
pression patterns of desmosomal cadherins, which medi-
ate cellular adhesions, are also affected by transmigrating
PMNs. Thus,we investigated the effect of PMNTEMon the
expression ofDsg-2, a key component of intestinal epithelial
desmosomes (15). PMN TEM assays in the physiologic
basolateral to apical direction toward a gradient of fMLF
(100nM,37°C)wereconductedaspreviouslydescribed (33).
Three hours after initiation of PMN TEM, IEC lysates and
cell supernatants were analyzed for E-cadherin and Dsg-2
expressionbyWesternblot.At this timepoint,;90%of total
applied PMNs had completed TEM (Fig. 1A).
Consistent with previous observations of PMN-
elastase–mediated cleavage of E-cadherin (34), we found
decreased expression of E-cadherin in IEC lysates (Fig.
1B) and appearance of a 100-kDa fragment in cell su-
pernatants after PMN TEM (Fig 1B). PMN TEM also
triggered a dramatic loss of Dsg-2. Furthermore, the
appearance of a low-molecular-mass band (100 kDa),
consistent with the molecular mass for a Dsg-2 cleavage
product (25),was observed in IEC lysates, suggesting that
the released Dsg-2 fragment binds to IECs in a paracrine
fashion. These findings show that transmigrating PMNs
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can induce cleavage of Dsg-2 in a manner similar to that
observed for E-cadherin. Indeed analysis of IEC super-
natants after PMN TEM revealed the appearance of
100 kDa Dsg-2 fragment confirming Dsg-2 cleavage.
Inhibition of PMN TEM using an anti-CD11b function-
blocking antibody [10 mg/ml (35)] decreased cleavage
of both E-cadherin and Dsg-2. The loss of Dsg-2 during
PMN TEM was further confirmed by immunofluores-
cence confocal microscopy (representative images, Fig. 1C,
and quantification, Fig. 1D).
Transmigrating PMNs secrete MPs with an
associated biologically active MMP-9
Circulating and tissue-infiltrating PMNs during inflam-
mation have been shown to modulate cellular function
through the secretion of MPs (27, 28, 36). Proteome anal-
ysis of human PMN-MPs revealed an abundant expres-
sion of MMP-9 (26). Because MMP-9 has been reported to
cleave Dsg-2 (25), we hypothesized that PMN-induced
cleavage of Dsg-2 during TEM is facilitated by MMP-9
associated with PMN-MPs. As previously described (23),
high levels of MMP-9 expression were detected on freshly
isolated (unstimulated) permeabilized PMNs (total levels)
by flow cytometry (Fig. 2A, B). MMP-9 expression was
significantly reduced (;50%) after TEM, supporting the
idea that PMNs secrete MMP-9 during activation (23). In
contrast, expression of membrane-anchored CD11b was
not significantly changed. Low-level MMP-9 expression
was also observed at the PMN cell surface, but was not
significantly altered by TEM (Fig 2C, D). Consistent
with PMN activation, CD11b was mobilized to the cell
surface after TEM. Total and cell surface expression of
MMP-9 was also evaluated by immunofluorescence
staining and confocal microscopy and is shown in rep-
resentative images (Fig 2E). Secretion of MMP-9 was
further confirmed by analyzing cell supernatants after
PMN TEM (Fig. 2F). Abundant levels of MMP-9 were
found to be associated with MPs secreted by PMNs
during TEM, suggesting that PMN-MPs can be an im-
portant source of MMP-9.
Elastase, one of the knownPMN-derivedproteinases to
cleave E-cadherin, was not found to associate with PMN-
MPs (not shown). Given this observation, we focused at-
tention on evaluating MMP-9 secretion patterns and its
association with PMN-MPs. PMN MMP-9 is primarily
contained in gelatinase (tertiary) granules (37) that can be
Figure 1. PMN migration across
epithelial monolayers results in
cleavage of E-cadherin and Dsg-
2. PMN migration across IECs
in the physiologic basolateral-
to-apical direction was induced
by the introduction of an fMLF
gradient. A) At 3 h after initia-
tion of PMN TEM, 87.2 6 4.1%
of the applied PMNs had com-
pleted TEM. B) Western blot
analysis of epithelial cell lysates
after PMN TEM (3 h) revealed
decreased expression of full-
length E-cadherin and Dsg-2.
For Dsg-2, appearance of a
low-molecular-mass fragment
(100 kDa) was observed, consis-
tent with Dsg-2 cleavage prod-
uct. Cleavage of both cadherins
was further conﬁrmed by assay-
ing IEC supernatants after PMN
TEM. Equal protein loading in
cell supernatants was conﬁrmed
with Ponceau protein stain. C)
Representative immunoﬂuores-
cence images demonstrate loss
of Dsg-2 during PMN TEM com-
pared to control IECs. PMNs
were stained for CD11b, red).
D) The relative ﬂuorescence in-
tensity was quantiﬁed in 10 ran-
domly selected ﬁelds of view,
with and without PMN TEM,
as an index of Dsg-2 expres-
sion. For immunoblots and
ﬂuorescence analysis, data are
representative of 3 indepen-
dent experiments. **P , 0.01;
***P , 0.001.
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mobilized to release their contents by PMN stimulation
with the chemoattractant fMLF (38). Thus, we examined
expression of MMP-9 on MPs isolated from fMLF-
stimulated PMNs. Using flow cytometry forward and
side light scattering,PMN-MPswerecomparedwith1-mm
beads. MPs smaller than 1 mm in diameter that stained
positive for phosphatidylserine [annexin V staining of
phosphatidylserine has been used to define PMN-derived
membrane particles (39)] and CD11b (a PMN marker)
were analyzed for MMP-9 expression (Fig. 3A). Hetero-
geneity in the size of PMN-derivedMPs (;100–800mm) is
highlighted by a representative electron microscopic im-
age (Fig. 3B). Consistent with reported proteomic analysis
data (26),we foundhigh levels ofMMP-9onPMN-MPsby
using flow cytometry (Fig. 3C) and Western blot analysis
(Fig. 3D). We next performed zymography analyses to
Figure 2. MMP-9 localizes to both PMN granules and cell surface and is secreted during PMN TEM. Expression of MMP-9 on
PMNs was examined by using ﬂow cytometric analysis. A, B) PMNs before and after TEM were ﬁxed, permeabilized, and stained
for MMP-9 and CD11b. Representative ﬂow diagrams (A) and quantiﬁcation (B) show a signiﬁcant decrease in total levels of
MMP-9 in PMNs after TEM. **P , 0.01. C, D) Analysis of surface expression of PMNs before and after PMN TEM (under
nonpermeabilized conditions) revealed detectable basal levels of surface MMP-9. PMN surface expression of MMP-9 was not
signiﬁcantly altered during TEM. ns, not signiﬁcant. ***P , 0.001. E) Representative immunoﬂuorescence images show total (top)
and surface MMP-9 (bottom) expression by permeabilized and nonpermeabilized PMNs, respectively. MMP-9 (green) on PMN
surface did not colocalize with CD11b (red). F) Release of MMP-9 by transmigrating PMNs was further conﬁrmed by Western blot
analysis. Secreted MMP-9 was detected in cell supernatants (soluble form) and associated with PMN-MPs after PMN TEM. Equal
protein loading in cell supernatants was conﬁrmed with Ponceau protein stain. For all panels, n = 3 independent experiments.
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examine whether MMP-9 associated with PMN-MPs is
enzymatically active. Application of PMN-MPs under
nonreducing conditions to SDS-PAGE resolving gels
containing gelatin as a substrate revealed proteolytic ac-
tivity of MMP-9 (Fig 3E). MMP-9 activity was enhanced
with an increasing number of PMN-MPs. Furthermore,
examination of proteolytic activity relative to protein ex-
pression (immunoblotting analysis) of MMP-9 on PMN-
MPs vs. soluble MMP-9 in PMN supernatants that were
cleared of MPs (both derived from 1 3 106 PMNs and
resuspended in the samevolume) revealed;5-fold higher
enzymatic activity of MMP-9 that was associated with
PMN-MPs.
Binding of PMN-MPs to IECs leads to
MMP-9-dependent cleavage of Dsg-2
After establishing association of enzymatically active
MMP-9 with PMN-MPs, we performed concentration
curve experiments to examine whether PMN-MPs could
bind to IECs and induce cleavage of Dsg-2, as observed
during PMN TEM (Fig. 1). In these experiments, MPs
isolated from 1, 2, and 33 106 PMNswere added to both
the basolateral and apical surfaces of IECs that were
grown on permeable supports in an inverted orientation
(Transwells, Corning, Inc., Corning NY, USA), and IEC
cell lysates were analyzed for MMP-9 expression as an
index of PMN-MP binding. Increased levels of MMP-9
were observed with increasing amounts of applied MPs
(Fig. 4A), suggesting specific contribution of PMN-MPs.
We observed the MMP-9 expression by non-cytokine–
treated IECs in the absence ofMPtreatment tobevery low
and detectable only after high Western blot exposure
(shown inFig. 6). PMN-MPbinding to IECs (derived from
2 3 106 PMNs, 3 h, 37°C) was further confirmed by im-
munofluorescence. PMN-MPs that stained positively for
CD11b (green) were observed to bind to IEC membrane
(red) (Fig. 4B). PMN-MP binding to IECswas sufficient to
induce cleavage of Dsg-2, but not of the tight junction
protein JAM-Aor theadherens junctionproteinE-cadherin
(Supplemental Fig. S1A). PMN-MP-mediated loss of
Dsg-2was evident in representative immunofluorescence
staining and quantification, respectively (Fig 4C, D). Fur-
thermore, an increase in Dsg-2 cleavage product (100-kDa
fragment) was observed in IEC lysates and supernatants
after PMN-MP treatment (Fig 4C). The loss of Dsg-2 and
the increase in Dsg-2 fragment formation (in cell super-
natants)wasMMP-9 dependent, as itwas reversed in the
presence of pharmacological inhibitor toMMP-9 (MMP-9
inhibitor II, 100 nM) but not to MMP-2 (MMP-2 inhibitor
IV, 200 nM; Fig. 4D and Supplemental Fig. S1B). Consis-
tent with unstimulated IECs expressing low levels of
MMP-9 and in line with previous findings (25),
Figure 3. Activated PMNs secrete microparticles with enzymatically active MMP-9. MPs were isolated from supernatants of fMLF-
stimulated PMNs (1 mM, 20 min, 37°C). A) The presence of PMN-derived MPs (,1 mm) in supernatants of activated PMNs was
conﬁrmed by ﬂow cytometry. SSC, side scatter; FSC, forward scatter. B) Transmission electron microscopy micrograph depicts the
heterogeneity in the size of PMN-derived MPs. C) PMN-MPs were further characterized by ﬂow cytometry for the expression of
membrane marker, annexin V and the speciﬁc myeloid marker CD11b. PMN-MPs that stained positive for both annexin V and
CD11b were also found to express high levels of MMP-9. D) CD11b and MMP-9 expression on MPs derived from fMLF-stimulated
PMNs was also conﬁrmed by Western blot analysis. E) Gel zymography conﬁrmed that MP-bound MMP-9 was enzymatically
active. MMP-9 enzymatic activity (as evident from collagen degradation) was enhanced with increasing concentration of MPs. All
panels are representative of at least 3 independent experiments. Ice, unstimulated PMNs kept on ice at all times.
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constitutive low level cleavage of Dsg-2 by IECs was ob-
servedunder control conditions (noPMN-MPs).Ourdata
suggest that IEC self-cleavage is also dependent on en-
dogenous MMP-9 activity, as it diminished after MMP-9
inhibition (Fig 4E). Together, these findings demonstrate
that, in addition to endogenous IEC proteinase activity,
PMN-MPs may act as a significant source of MMP-9 to
cleave Dsg-2.
PMN-MP binding to IECs induces MMP-9
dependent disruption of epithelial cell-to-
cell adhesions
Loss of Dsg-2 reduces intercellular adhesion strength,
leading to impaired IEC monolayer integrity (40). Given
our observation of PMN-MP-mediated cleavage of Dsg-2,
we used a well-established Dispase assay (40) to examine
whether PMN and PMN-MP binding to IECs could
disrupt the integrity of monolayers. PMN adhesion to
IECs (2 3 106 cells/well in a 6-well plate, 3 h, 37°C)
induced by fMLF (100 nM, had no effect on IECs) trig-
gered a robust fragmentation of epithelial monolayers
(Fig. 5A). PMN-MP treatment alone (derived from 2 3
106 PMNs, 3 h, 37°C) was sufficient to achieve similar
effects (Fig. 5B, C). IEC stimulation with TNFa (100 ng)
was used as a positive control, as TNFa at this concen-
tration has been shown to activate endogenous,
epithelium-derived MMP-9, leading to increased Dsg-2
cleavage and increased monolayer fragmentation (25).
Intriguingly, the effect of MPs (derived from 2 3 106
PMNs) was more potent than that of TNFa (100 ng),
suggesting that in addition or parallel to endoge-
nous (epithelium-derived) MMP-9, exogenous (PMN-
derived)MMP-9 significantly contributes to the regulation
of epithelial integrity in conditions of inflammation.
Figure 4. PMN-MP binding to IECs leads to MMP-9-dependent cleavage of Dsg-2. To examine the effect of PMN-MP binding to
IEC membrane on Dsg-2 expression and cleavage, PMN-MPs were added to both the upper and lower chambers of cell-migration
assay plates, so that both the basolateral and apical IEC surfaces were exposed to treatment (3 h, 37°C). A) MPs derived from an
increasing number of PMNs (as indicated) were incubated with IECs, and their binding was examined by Western blot analysis.
B) PMN-MP (derived from 2 3 106 PMNs) binding to IECs was further examined with ﬂuorescence microscopy. Representative
immunoﬂuorescence images show that PMN-MPs (positive for CD11b, green) bound to IECs with high efﬁciency. The IEC
surface was visualized with a membrane stain, cell mask (orange). C) Representative immunoﬂuorescence images (top) show
that PMN-MP binding to epithelial cells led to decreased expression of Dsg-2 (red: Dsg-2; blue: nuclei). A Z-stack 3-dimensional
surface plot (bottom) shows decreased levels of Dsg-2 expression at the basolateral/apical cell borders. D) Quantiﬁcation of the
relative Dsg-2 expression based on ﬂuorescence staining from 3 independent experiments (n = 50 cell/condition). **P, 0.01. E)
Western blot analysis conﬁrmed that PMN-MP binding to IECs induced cleavage of Dsg-2. Although constitutive low-level
cleavage of Dsg-2 by IECs was observed, treatment with PMN-MPs dramatically increased the abundance of a 100-kDa Dsg-2
cleavage product (Dsg-2 f) both in cell supernatants and in cell lysates. PMN-MP-mediated cleavage of Dsg-2 was MMP-9
dependent, as it was reversed in the presence of an MMP-9 inhibitor (MMP-9 inhibitor II, 100 nM). Constitutive IEC-mediated
cleavage of Dsg-2 was similarly suppressed in the presence of MMP-9 inhibitor. Blots are representative of 4 independent
experiments.
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Dose–response experiments confirmed that increasing
the number of PMN-MPs or the concentration of TNFa
had no additional effect on the monolayer adhesion
strength (Fig. 5D).
Consistent with increased monolayer fragmentation
induced by PMN-MPs compared with TNFa, under
similar conditions PMN-MPs were more effective in
mediating Dsg-2 cleavage (Fig. 5E). The effects of
PMNs, PMN-MPs, and TNFa were reversed in the pres-
ence of MMP-9 but not MMP-2 inhibitor, indicating a
specific role forMMP-9 in these responses. Together, these
findings implicate MP secretion by migrating PMNs and
their binding to IECs as a potential mechanism by which
PMNs may induce disruption of epithelial intercellular
adhesions.
MP deposition by activated PMNs facilitates
PMN TEM in vitro
Given the ability of PMN-MPs to mediate cleavage of
Dsg-2 anddisrupt IEC integrity (Figs. 4, 5),we examined the
Figure 5. PMN-MP binding to IECs results in MMP-9 dependent disruption of epithelial cell-to-cell adhesions. Dispase-based
dissociation assay was used to assess the strength of intercellular adhesions and monolayer integrity after the indicated treatments.
A) Freshly isolated PMNs were added to IEC monolayers and induced to adhere in the presence of 100 nM fMLF (2 3 106 PMNs/
well, 3 h, 37°C). PMN adhesion to IECs resulted in signiﬁcant fragmentation of IEC monolayers, which was dependent on MMP-9
activity, after Dispase treatment. ***P , 0.001. Data presented are an average of 3 independent experiments. B) Addition of PMN-
MPs to IECs (MPs derived from 2 3 106 PMNs, 2 h, 37°C) resulted in signiﬁcant fragmentation of IEC monolayers, similar to the
observed effect of PMNs. TNFa treatment (100 ng) was used as a positive control, as it is known to induce MMP-9 activity in IECs,
leading to increased cleavage of Dsg-2. The effects of PMNs and PMN-MPs, as well as TNFa treatment, were dependent on MMP-9
activity and were reversed in the presence of MMP-9 inhibitor (MMP-9 inhibitor II, 100 nM). No cumulative effect of PMN-MP and
TNFa treatment was observed. ***P , 0.001; 3 independent experiments. C) Representative images of the Dispase assay showed
fragmentation of the IEC monolayers after the speciﬁed treatments. D) To determine the optimal treatment dose, the effect of an
increasing number of PMN-MPs and increasing concentration of TNFa on IEC monolayer fragmentation were examined. E)
Consistent with the signiﬁcantly more potent effect of PMN-MPs on monolayer fragmentation compared to TNFa treatment
(100 ng), PMN-MP treatment was also more effective in inducing Dsg-2 cleavage.
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possibility thatMPdeposition onto IECsbyPMNs serves
as a mechanism to promote PMN TEM. In these experi-
ments, PMN TEM assays (33, 35) were performed after
pretreatment of T84 IECs with PMN-MPs (derived from
2 3 106 PMNs, 3 h, 37°C). Consistent with the observed
PMN-MP-induced loss of Dsg-2 and disruption of cell-
to-cell adhesions, pretreatment of IECs with PMN-MPs
elicited a significant increase in PMNTEM (Fig. 6A). The
PMN-MP-mediated increase in PMN TEMwas reversed
with the addition of general MMP and specific MMP-9
inhibitors (GM6001, 100 mM, and MMP-9 inhibitor II,
100 nM, respectively) but not an inhibitor of MMP-2
(MMP-2 inhibitor IV, 200 nM). We further established
that PMN-MPs did not directly induce PMN-chemotaxis
(not shown), confirming the role for PMN-MP associated
MMP-9 in regulation of PMN TEM.
To determine whether Dsg-2 contributes to the regu-
lation of PMN TEM and confirm that the observed PMN-
MP effects were due to loss of Dsg-2, PMN TEM was
examined after siRNA–mediateddown-regulationofDsg-2
or after IEC treatment with an inhibitory anti-galectin
(Gal)-3 antibody (M3/38). We recently established that
Figure 6. Dsg-2 and PMN-derived MMP-9 collectively regulate PMN TEM. A) To examine whether PMN-MP binding to IECs can
affect PMN TEM, assays were performed after IEC preincubation with PMN-MPs (derived from 2 3 106 PMNs, 3 h, 37°C). MP
treatment of IECs signiﬁcantly enhanced PMN TEM. The increase in PMN TEM was prevented by the addition of MMP-9, but not
by MMP-2 inhibitors. **P , 0.01. B) To determine the contribution of Dsg-2 to the regulation of PMN TEM, PMN TEM assays
were performed after siRNA- or antibody (anti-Gal-3 inhibitory antibody, M3/38)-mediated down-regulation of Dsg-2. Loss of
Dsg-2 resulted in signiﬁcantly enhanced PMN TEM, similar to that observed with PMN-MPs. *P, 0.05. C) The efﬁciency of Dsg-2
down-regulation by siRNA is shown by representative immunoblots. D) To establish the role of IEC-derived MMP-9 in PMN TEM,
IEC monolayers were pretreated with pharmacological MMP inhibitors (MMP-9 inhibitor II, 100 nM; pan-MMP inhibitor,
GM6001, 10 mM; or MMP-2 inhibitor IV, 200 nM, 1 h, 37°C) or with MMP-9 siRNA. Immediately before the addition of PMNs,
IECs were washed, so that migrating PMNs were not exposed to the inhibitors. No signiﬁcant effects of inhibitors on PMN TEM
were observed. ***P, 0.001. E) PMN TEM assays were performed in the presence of MMP inhibitors (added to the top chamber
of cell-migration assay plates at the same time as PMNs) to ensure exposure of both PMNs and IECs. Inhibition of MMP-9 using
speciﬁc MMP-9 inhibitor or pan-MMP inhibitor, but not MMP-2 inhibitor, signiﬁcantly decreased PMN TEM. ***P , 0.001. F) The
efﬁciency of MMP-9 down-regulation by siRNA both in cell lysates and in supernatants (secreted MMP-9) is shown by representative
immunoblots. A, B, D, E) Three independent experiments where at least 3 migration assays were used for each condition. C, F)
Immunoblots are representative of 3 independent experiments.
NEUTROPHIL MICROPARTICLES DISRUPT EPITHELIAL ADHESIONS 4015
M3/38 inhibits Gal-3 binding to Dsg-2, leading to its de-
pletion from epithelial junctions (40). For both treatments,
down-regulation of Dsg-2 resulted in significant increases
in PMN TEM (Fig. 6B), similar to the observed effects of
PMN-MPs. The efficiency of Dsg-2 down-regulation by
siRNA is shown by representative immunoblots (Fig. 6C).
Thedown-regulation hadno effect on levels of E-cadherin.
These findings suggest that Dsg-2 serves as a barrier for
transmigrating PMNs and that PMN-MPs, by removing
Dsg-2 from junctions, promote PMN TEM.
PMN-derived MMP-9 facilitates PMN TEM
Depending on the cell type used, MMP-9 has been found
to either promote (41) or not to be involved (42) in PMN
transmigration. The findings in this study suggest that, in
IECs, MMP-9 facilitates PMN TEM by mediating Dsg-2
cleavage. To directly test this idea, we conducted PMN
TEMassays in the presence of pan-MMP, specificMMP-9,
and control MMP-2 inhibitors. Treatment with both pan-
MMPandMMP-9, but notMMP-2 inhibitors, significantly
attenuated PMN TEM (Fig. 6D), confirming the role of
MMP-9 in facilitating this process. Similar increases in
PMN TEM were obtained with preincubation of PMNs
with inhibitors before the initiation of PMNTEM (data not
shown), suggesting an important contribution of PMN-
derived MMP-9 to PMN TEM.
Because IECs express endogenous MMP-9, we also
examined thepotential contributionof IEC-derivedMMP-
9 toPMNTEM. In these experiments IECswerepretreated
with the aforementioned inhibitors (40 min, 37°C), which
were then removed and PMN TEM assays were per-
formed. Neither inhibitor had a significant effect on PMN
TEM (Fig. 6E). Similar results were obtained when PMN
TEM assays were conducted after siRNA-mediated
down-regulation of IEC MMP-9 expression (Fig. 6E).
Under siRNA conditions, the addition of an MMP-9
inhibitor to migrating PMNs significantly attenuated
PMN TEM. The decrease in MMP-9 expression after
siRNA treatment was confirmed both in IEC lysates
and IEC supernatants by immunoblot analysis (Fig. 6F).
Together, these findings suggest that PMN-derived
MMP-9 rather then IECMMP-9 plays an important role
in PMN TEM.
PMN-MPs promote cleavage of Dsg-2 in vivo
to increase PMN TEM
To examine the effect of PMN-MPs on Dsg-2 expression
and PMN recruitment in vivo, we isolated murine MPs
from fMLF (5 mM)-stimulated bone marrow–derived
PMNs (mPMN-MPs; confirmed to display activeMMP-9;
Fig. 7A) and introduced them into ligated murine ileal
loops (MPs derived from 53 106 PMNs, 3 h). The number
of PMNs that migrated into the intestinal lumen and the
mucosal tissuewasquantifiedby flowcytometryof lavaged
ileal loops (200 ml sterile HBSS+) and immunofluorescence
labeling (35).
Consistent with observations in cultured IECs, mPMN-
MP treatment triggered dramatic loss of Dsg-2 from the
apical epithelial junctional complexes (representative
immunofluorescence images, Fig. 7B). Paralleling loss
of Dsg-2, a significant influx of PMNs into the in-
testinal lumen and the mucosal tissue was observed
after treatment with mPMN-MP (representative flow
diagrams, Fig. 7C, and fluorescence images, Fig. 7E).
As expected, no PMNs were detected in the lumen of
control intestines.
Addition of lipopolysaccharide (LPS, 100 mg/ml,
1 h) in combination with mPMN-MPs treatment (LPS
was added 2 h after initial administration of PMN-
MP) further increased the number of PMNs in-
filtrating the intestinal lumen. Administration of LPS
alone into ligated ileal loops induced only moderate
PMN migration (Fig. 7D), without having significant
effects on Dsg-2 expression (not shown). Similar to in
vitro observations, mPMN-MP induced loss of Dsg-2
and increased PMN TEM in vivo, were MMP-9 de-
pendent, and were diminished in the presence of
MMP-9 (5 mg/kg body weight) and pan-MMP
(100 mg/kg body weight, not shown), but not
MMP-2 (10 mg/kg body weight) inhibitors. Finally,
to examine whether Dsg-2 is involved in the regula-
tion of PMN TEM in vivo, we used an established
approach (35, 42), where administration of M3/38 (an
anti-Gal3 mAb, 50 mg, 2 h) into ligated ileal loops
resulted in acute depletion of Dsg-2 in intestinal epi-
thelium (40). M3/38 but not IgG control antibody
triggered increased PMN infiltration of the intestinal
lumens (Fig. 7D).M3/38-mediated loss ofDsg-2 is a result
of increased Dsg-2 internalization and proteasome
degradation but not cleavage (40). Thus, as expected,
the observed M3/38-induced increases in PMN TEM
were MMP-9 independent. Together, these findings
suggest that PMN-MPs released during PMN TEM
cleave Dsg-2 via an MMP-9-dependent mechanism and
impair IEC integrity and facilitate increases in PMN
recruitment in vivo.
DISCUSSION
PMNmigration across epithelial monolayers under the
conditions of inflammation often leads to barrier dys-
function and tissue injury (17, 33). Release of MPs by
various cell types, including activated PMNs, has re-
cently come into focus as a new mechanism of cellular
communication. Indeed, MPs generated by platelets
and endothelial cells have been implicated in several
vascular diseases, where theywere shown to contribute
to regulation of the coagulation cascade and vascular
homeostasis (36). Although the function of PMN-MPs is
less understood, there is evidence that PMN-MPs be-
come highly enriched at sites of inflammation (28, 43).
PMN-MPs were further suggested to be biologically
active and respond to external stimuli by generating
ROS or producing leukotriene B4 (26). In the current
work, we demonstrate that activated PMNs during
TEM secrete MPs that display high levels of enzymati-
cally activeMMP-9. It is not yet clearwhether theMMP-
9 that is carried by PMN-MPs is packaged inside or is
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associated with the MP surface; however, PMN-MP
binding to IECs induced MMP-9-dependent cleavage
of Dsg-2, leading to impaired IEC integrity. Although
other proteolytic cleavage events are likely to occur
during PMNTEM, our findings demonstrate PMN-MP-
mediated cleavage of Dsg-2, but not E-cadherin or JAM-A,
supporting a role for Dsg-2 in TEM.
MMP-9 localizes primarily to PMN granules (31, 44);
however, we observed low MMP-9 expression on the
PMN surface. Although it is possible that low MMP-9
expression on PMN surface is a result of mild PMN acti-
vation during the isolation process, the observation that
MMP-9 surface expression did not change after activation,
and TEM suggests otherwise.
Immunofluorescence staining revealed that MMP-9
exhibited punctate distribution similar to that reported for
CD11b (45), but did not colocalize with CD11b, which is
typically expressedonmembrane ruffles (46). It remains to
be determined whether MMP-9 expressed at the PMN
surface associates with another protein or nonspecifically
coats PMN membranes. The total levels of PMN MMP-9
were significantly decreased after PMN TEM. Decreased
levels of MMP-9 were accompanied by an increased
presence of MMP-9 in cell supernatants, consistent with
the previously established release of MMP-9 by activated
PMNs.
Consistent with recent proteomic analysis that
revealed the presence of MMP-9 on MPs derived from
fMLF-activated PMNs (26), we found abundant asso-
ciation of MMP-9 with PMN-MPs. We further estab-
lished that MMP-9 carried by PMN-MPs exhibited high
proteolytic activity (assessed by collagen degradation)
and thus could mediate changes in the surrounding
tissue. Moreover, PMN-MP-bound MMP-9 exhibited
Figure 7. PMN-MP treatment of murine intestines promotes PMN TEM in vivo. Murine MPs were prepared from bone
marrow–derived PMNs. A) Gel zymography was used to conﬁrm that mPMN-MPs expressed enzymatically active MMP-9. MMP-9
enzymatic activity (as evident from collagen degradation) was enhanced with an increasing concentration of MPs. B) To examine
the effect of mPMN-MPs on Dsg-2 expression and distribution in vivo, mPMN-MPs were administered intraluminally into ligated
ileal loops (MPs were derived from 5 3 106 PMNs for 3 h). After PMN-MP incubation, tissue from ileal loops was prepared for
immunoﬂuorescence imaging analysis. A dramatic loss of Dsg-2 (green) from the apical junctional regions was observed. Scale
bar, 50 mm. C–E) In separate experiments, after mPMN-MP treatment, PMNs that migrated into the lumen were isolated by
lavage and quantiﬁed using ﬂow cytometric analysis. C) Representative ﬂow diagrams (n = 5 mice/condition) depict mPMN-MP-
induced PMN migration into the intestinal luminal space. PMN migration was further potentiated with the addition of LPS or
M3/38-mediated down-regulation of Dsg-2. D) Quantiﬁcation of data from C. E) Representative immunoﬂuorescence images of
cryosections from the ileum show PMN inﬁltration (red) of the intestinal epithelia (outlined by actin staining, green) and the
lumen after mPMN-MP treatment (n = 5 mice/condition). Scale bar, 50 mm.
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higher activity compared to MMP-9 secreted in the
soluble form. Soluble MMP-9 could add to the effects of
PMN-MP-bound MMP-9; however, its relative contri-
bution compared to PMN-MP-bound MMP-9 remains
to be determined. MPs have been suggested to increase
stability and improve transport of functional pro-
teins across tissue (47). Thus, tissue-infiltrating PMNs
releasing MPs carrying MMP-9 with high proteo-
lytic activity may be a mechanism to ensure efficient
remodeling of the epithelial monolayers and the sur-
rounding matrix during TEM. Indeed, tissue remod-
eling is essential for proper PMN trafficking. As such,
inability to remodel endothelial junctional compo-
nents, such as VE-cadherin (48), cell cytoskeleton
(49), and the extracellular matrix (50), inhibits PMN
transmigration.
PMN-MPs are emerging as important contributors to
regulation of tissue function and homeostasis; however,
whether theymediate beneficial or adverse effects under
inflammatory conditions is still unclear. For example,
PMN-MP binding to endothelial cells has been sug-
gested to be proinflammatory and induce cell injury (51),
whereas MPs binding to PMNs decrease the PMNs’
ability to adhere and migrate across endothelial cells
(39). Similarly, binding of PMN-MPs to natural killer
cells and macrophages exerts an anti-inflammatory ac-
tivity diminishing their responses, thus potentially fa-
voring the resolution of inflammation (28, 52). Finally,
the ability of PMN-derived microvesicles to enter carti-
lage has been recently shown to protect the joint in in-
flammatory arthritis (43).
In our setup, binding of PMN-MPs to polarized
IECs induced MMP-9-dependent cleavage of Dsg-2,
leading to impaired integrity of IEC monolayers and
increased PMN tissue infiltration. Indeed, in in-
flammatory bowel diseases, which are characterized
by a high number of infiltrating PMNs, decreasedDsg-
2 expression correlates with increased inflammation
and severity of the disease (19). Furthermore, cleaved
ectodomains of Dsg-2 have been detected in inflamed
intestinal mucosa of colitic mice and patients with ul-
cerative colitis (25). As has been recently demonstrated
by Kamekura et al. (25), and confirmed in this work,
secretion of proinflammatory cytokines, such as TNFa
or IFNg, by IECs or tissue infiltrating leukocytes can
trigger activation of IEC MMPs, leading to Dsg-2
cleavage and epithelial dysfunction. Our current find-
ings suggest that, during acute inflammation that is
characterized by a high number of mucosa-infiltrating
PMNs, PMN-MPsmay serve as anothermajor source of
MMP-9 and exert inflammatory effects, contributing to
tissue injury and symptomatic disease.
Our findings further suggest that Dsg-2 serves as a
barrier for transmigrating PMNs, preventing both
PMN tissue accumulation and the resulting tissue
damage. Thus, stabilizing Dsg-2 at the cell junctions or
developingmethodologies to prevent its cleavagemay
prove to be effective approaches to promoting the
resolution of inflammation. Similarly, our study sug-
gests a role for MMP-9 in regulating PMN migration
across IECs, because of its ability to cleave Dsg-2 and
remove its inhibitory effects on PMNTEM. Supporting
this idea, PMN migration across endothelial cells,
which in most cases do not express Dsg-2, has been
found to be MMP-9 independent (53).
Finally, loss of Dsg-2 and E-cadherin is considered
a hallmark of epithelial-to-mesenchymal transition,
given that they serve to maintain epithelial cell polarity
and prevent cell migration and invasion of other tissues
(54, 55). The observation that PMNs can deposit MPs
rich in MMP-9 onto epithelial surfaces, where MMP-9
can mediate cleavage of Dsg-2, may implicate tissue-
infiltrating PMNs in promoting tumorigenesis. These
data thus provide a direct link between inflammation
and cancer, strengthening the prevailing view that im-
mune cell–mediated inflammation is a major risk factor
for the development of variousmalignancies, including
lung, ovarian, colorectal, and pancreatic carcinomas
(56, 57).
In summary, the current work demonstrated that
tissue-infiltrating PMNs releaseMPswith enzymatically
active MMP-9 that binds to IECs and triggers acute
remodeling of epithelial junctions and decreased inter-
epithelial adhesions, leading to enhanced recruitment of
PMNs. Our studies define a new mechanism by which
PMNs infiltrating the intestinal mucosa disrupt IEC
junctions to facilitate PMN TEM, thus likely contribut-
ing to disease pathology in a variety of inflammatory
conditions.
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